Read Article(All)

The list of (1) News and Articles (for free)
and (2) "U.S. eHealth Journal" (in Japanese, Subscription required)
貴社ビジネスをサポートする情報発信を目指します。
① 日米のヘルスケア産業情報 (無料) → ② 「米国eHealthジャーナル」(要･購読契約)

11-20 of 690 articles

[米国製薬業界週報] ANDA提出可能性、参照製品の年間売上に比例

FDA医薬品評価研究センター（CDER）の研究班は10月28日、簡易新薬承認申請（ANDA）がFDAに提出される可能性を予測し得る要因について調査した結果を発表した。2011～2017年...

Target market

USA
Business category

Pharmaceutical
Business function
Author

"Yukako Goshima" of "MSA Partners, LLC"
Availability

Membership

[中国ニュース]新型コロナ禍中の中国医療

2021年の冬、世界で初となる新型コロナウイルス市中感染の発生から一年が経過した中国は、既に日常を取り戻しつつあるように感じられる。報道される感染例は少なく...

Target market

Other countries
Business category

Others
Business function
Author

"Lily (Yu Zhixiao)" of "CM Plus Corporation"
Availability

Membership

[米国製薬業界週報] FDA、医薬品開発ツール認定プログラムを拡大

FDAは11月30日、医薬品開発ツール（以下DDT）の開発促進を目的に、「新薬のための革新的科学技術アプローチ（Innovative Science and TechnologyApproaches fo...

Target market

USA
Business category

Pharmaceutical
Business function
Author

"Yukako Goshima" of "MSA Partners, LLC"
Availability

Membership

[米国製薬業界週報] CMS、2019年の米国医療支出を発表

メディケア・メディケイド・サービスセンター（CMS）の保険数理室は12月16日、2019年の米国医療支出は前年比4.6％増の3兆8,000億ドルだったと発表した。2019年の医療支出...

Target market

USA
Business category

Pharmaceutical
Business function
Author

"Yukako Goshima" of "MSA Partners, LLC"
Availability

Membership

[Yakuji Nippo]
Requested for Preparation for Digitization of Package Inserts - GS1 Code Reading, etc.

On February 19, The Ministry of Health, Labor and Welfare (MHLW) issued a notice requesting marketing authorizatio...

Target market

Japan
Business category

Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
Business function

Marketing >
Author

"LSMIP Editorial Office" of "CM Plus Corporation"
Availability

Membership

[Yakuji Nippo]
Publishing a list of drugs requiring stability protection-506 items such as Cefazolin

On February 26, the Ministry of Health, Labor and Welfare (MHLW) announced 506 items in its proposal about "Ens...

Target market

Japan
Business category

Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
Business function

Marketing >
Author

"LSMIP Editorial Office" of "CM Plus Corporation"
Availability

Membership

[Yakuji Nippo]
Issued Business Suspension Order to Nichi-Iko - Inappropriate Manufacturing at Toyama Plant 1

On March 3, Toyama Prefecture issued business suspension orders to Nichi-Iko for the issue of its manufacturing and ...

Target market

Japan
Business category

Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
Business function

Marketing >
Author

"LSMIP Editorial Office" of "CM Plus Corporation"
Availability

Membership

[米国製薬業界週報] FDA、2020年度のジェネリック薬承認件数を発表

FDAは10月16日、2020会計年（2019年10月～2020年9月）に承認したジェネリック医薬品に関する報告書を発表した。それによると、651件を承認した2016年度から4年連続で増加...

Target market

USA
Business category

Pharmaceutical
Business function
Author

"Yukako Goshima" of "MSA Partners, LLC"
Availability

Membership

[米国製薬業界週報] FDA、希少疾患治療薬開発にグラント提供

FDAは10月8日、「希少疾患製品グラント・プログラム（Orphan Products Grants Program）」に基づき、学術界や産業界の希少疾患治療薬開発に対し臨床試験研究グラント6件を供与す...

Target market

USA
Business category

Pharmaceutical
Business function
Author

"Yukako Goshima" of "MSA Partners, LLC"
Availability

Membership

February 18, 2021

[Yakuji Nippo]Business Suspension Order to Kobayashi Kako Co., Ltd for 116 Days - Longest Ever, For Keeping Quiet about Manufacturing Conditions

Data Fabrication and Dual Bookkeeping as WellRegarding the case of the health damage that occurred due to a sleep-in...

Target market

Japan
Business category

Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
Business function

Marketing >
Author

"LSMIP Editorial Office" of "CM Plus Corporation"
Availability

Membership

What information are you looking for in articles?
Let us help you to find out the articles for your business requirements!

Contact Us

Like many other companies, we use cookies and other technologies, some of which are essential to make our website work. By clicking Accept or continuing to use our site, you agree to use these cookies and other technologies. To learn more, check out our privacy policy.

Accept